An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
Clinical trial NCT00002205 · COMPLETED
Trial details
- NCT number
- NCT00002205
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.